Recently, a study showed that inhibition of the Src/Ets1 pathway, which results in downregulation of Ets1 protein level, may provide treatment for cisplatin-resistant head and neck squamous cell carcinoma[16]. This evidence concerns the gene ETS1 and head and neck squamous cell carcinoma.